Cargando…
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
Despite recent therapeutic progress and improved survival for many patients with primary central nervous system lymphoma (PCNSL), up to 50% of patients will experience refractory or relapsed disease following first-line treatment with high dose methotrexate (HD-MTX) based regimens. The majority of s...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612457/ https://www.ncbi.nlm.nih.gov/pubmed/35253010 http://dx.doi.org/10.21037/aol-21-20 |